Advion is a CVF portfolio company. It has a stable of very well-known investors (Aisling, Skyline, Polaris), and is currently the largest company (in terms of revenue and employees) in our portfolio. Advion has 2 operating business, namely (i) a Contract Research Organization (CRO), which is a premier bioanalytical service laboratory specializing in liquid chromatography – tandem mass spectrometry (LC/MS/MS) services, and (ii) a products business, which is the scientific leader in microfluidics systems for chemistry and biochemistry applications.
I am very pleased to announced that last night Advion signed a definitive agreement to sell its CRO business. This is a great outcome for the company and the Ithaca community. You can read the company’s press release here.
We continue to have a meaningful ownership stake in the products business! Go Advion!!